Both in Pharmaceuticals
Altimmune vs Sagimet Biosciences Inc. Series A
Over the past year ALT returned −21.6% and SGMT returned +34.8%; their daily moves had a correlation of 0.24.
ALT −21.6% SGMT +34.8%Growth of $1, one year, split-adjusted
| Metric | ALT | SGMT |
|---|---|---|
| Price | $2.97 | $9.33 |
| Market cap | $577.7M | $579.9M |
| Today | +0.34% | −6.14% |
| 1 month | −4.5% | −11.6% |
| 6 months | +3.1% | +105.1% |
| Year to date | −17.7% | +57.6% |
| 1 year | −25.8% | +27.1% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 18,636.1× | — |
| Net cash | $291.5M | $240.1M |
| Dividend yield | — | — |
| Volatility (60d) | 46.0% | 69.4% |
| Short % of float | 28.1% | 36.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).